Prioritizing human cancer microRNAs based on genes' functional consistency between microRNA and cancer

Nucleic Acids Research

Volumn 39, Issue 22, 2011, Pages

  Li, Xia ^a   Wang, Qianghu ^a   Zheng, Yan ^a   Lv, Sali ^a   Ning, Shangwei ^a   Sun, Jie ^a   Huang, Teng ^a   Zheng, Qifan ^a   Ren, Huan ^a   Xu, Jin ^a   Wang, Xishan ^a   Li, Yixue ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 27A; MICRORNA 27B; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CANCER GENETICS; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FUNCTIONAL CONSISTENCY SCORE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL COMPUTING; ONCOGENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SCORING SYSTEM; THYROID CANCER; UPREGULATION;

COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MICRORNAS; NEOPLASMS; THYROID NEOPLASMS;

EID: 83755205389     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr770     Document Type: Article

References (80)

1. Ambros,V. (2004) The functions of animal microRNAs. Nature, 431, 350-355. (Pubitemid 39265675)
2. Jovanovic,M. and Hengartner,M.O. (2006) miRNAs and apoptosis: RNAs to die for. Oncogene, 25, 6176-6187. (Pubitemid 44527848)
3. Lynam-Lennon,N., Maher,S.G. and Reynolds,J.V. (2009) The roles of microRNA in cancer and apoptosis. Biol. Rev. Camb. Philos. Soc., 84, 55-71.
4. Schickel,R., Boyerinas,B., Park,S.M. and Peter,M.E. (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene, 27, 5959-5974.
5. He,L., He,X., Lim,L.P., de Stanchina,E., Xuan,Z., Liang,Y., Xue,W., Zender,L., Magnus,J., Ridzon,D. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134. (Pubitemid 47014436)
6. He,L., Thomson,J.M., Hemann,M.T., Hernando-Monge,E., Mu,D., Goodson,S., Powers,S., Cordon-Cardo,C., Lowe,S.W., Hannon,G.J. et al. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833. (Pubitemid 40839734)
7. Voorhoeve,P.M. (2010) MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity? Biochim. Biophys. Acta, 1805, 72-86.
8. Zhang,B., Pan,X., Cobb,G.P. and Anderson,T.A. (2007) microRNAs as oncogenes and tumor suppressors. Dev. Biol., 302, 1-12. (Pubitemid 46096921)
9. Calin,G.A. and Croce,C.M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866. (Pubitemid 44629897)
10. Volinia,S., Calin,G.A., Liu,C.G., Ambs,S., Cimmino,A., Petrocca,F., Visone,R., Iorio,M., Roldo,C., Ferracin,M. et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA, 103, 2257-2261. (Pubitemid 43271657)
11. Yanaihara,N., Caplen,N., Bowman,E., Seike,M., Kumamoto,K., Yi,M., Stephens,R.M., Okamoto,A., Yokota,J., Tanaka,T. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198. (Pubitemid 43357945)
12. Baskerville,S. and Bartel,D.P. (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA, 11, 241-247. (Pubitemid 40270816)
13. Gaur,A., Jewell,D.A., Liang,Y., Ridzon,D., Moore,J.H., Chen,C., Ambros,V.R. and Israel,M.A. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res., 67, 2456-2468. (Pubitemid 46548930)
14. Gutierrez,N.C., Sarasquete,M.E., Misiewicz-Krzeminska,I., Delgado,M., De Las Rivas,J., Ticona,F.V., Ferminan,E., Martin- Jimenez,P., Chillon,C., Risueno,A. et al. (2010) Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling. Leukemia, 24, 629-637.
15. Lu,J., Getz,G., Miska,E.A., Alvarez-Saavedra,E., Lamb,J., Peck,D., Sweet-Cordero,A., Ebert,B.L., Mak,R.H., Ferrando,A.A. et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-838. (Pubitemid 40839735)
16. Barad,O., Meiri,E., Avniel,A., Aharonov,R., Barzilai,A., Bentwich,I., Einav,U., Gilad,S., Hurban,P., Karov,Y. et al. (2004) MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res., 14, 2486-2494. (Pubitemid 40012232)
17. Chen,Y., Gelfond,J.A., McManus,L.M. and Shireman,P.K. (2009) Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics, 10, 407.
18. Saba,R. and Booth,S.A. (2006) Target labelling for the detection and profiling of microRNAs expressed in CNS tissue using microarrays. BMC Biotechnol., 6, 47.
19. Bandyopadhyay,S. and Bhattacharyya,M. (2009) Analyzing miRNA co-expression networks to explore TF-miRNA regulation. BMC Bioinformatics, 10, 163.
20. Gennarino,V.A., Sardiello,M., Avellino,R., Meola,N., Maselli,V., Anand,S., Cutillo,L., Ballabio,A. and Banfi,S. (2009) MicroRNA target prediction by expression analysis of host genes. Genome Res., 19, 481-490.
21. Backes,C., Meese,E., Lenhof,H.P. and Keller,A. (2010) A dictionary on microRNAs and their putative target pathways. Nucleic Acids Res, 38, 4476-4486.
22. Bandyopadhyay,S., Mitra,R., Maulik,U. and Zhang,M.Q. (2010) Development of the human cancer microRNA network. Silence, 1, 6.
23. Shen,E., Diao,X., Wei,C., Wu,Z., Zhang,L. and Hu,B. (2010) MicroRNAs target gene and signaling pathway by bioinformatics analysis in the cardiac hypertrophy. Biochem. Biophys. Res. Commun., 397, 380-385.
24. Ravasz,E., Somera,A.L., Mongru,D.A., Oltvai,Z.N. and Barabasi,A.L. (2002) Hierarchical organization of modularity in metabolic networks. Science, 297, 1551-1555. (Pubitemid 34971002)
25. Goh,K.I., Cusick,M.E., Valle,D., Childs,B., Vidal,M. and Barabasi,A.L. (2007) The human disease network. Proc. Natl Acad. Sci. USA, 104, 8685-8690. (Pubitemid 47175372)
26. Wang,D., Wang,J., Lu,M., Song,F. and Cui,Q. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics, 26, 1644-1650.
27. Pesquita,C., Faria,D., Falcao,A.O., Lord,P. and Couto,F.M. (2009) Semantic similarity in biomedical ontologies. PLoS Comput. Biol., 5, e1000443.
28. Hugo Bastos,B.T., Pesquita,C., Faria,D. and Couto,F. (2011) Application of Gene Ontology to gene identification. Methods Mol. Biol., 760, 141-157.
29. The Gene Ontology in 2010: extensions and refinements. (2010) Nucleic Acids Res., 38, D331-D335.
30. Osborne,J.D., Flatow,J., Holko,M., Lin,S.M., Kibbe,W.A., Zhu,L.J., Danila,M.I., Feng,G. and Chisholm,R.L. (2009) Annotating the human genome with Disease Ontology. BMC Genomics, 10(Suppl. 1), S6.
31. Robinson,P.N., Kohler,S., Bauer,S., Seelow,D., Horn,D. and Mundlos,S. (2008) The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am. J. Hum. Genet., 83, 610-615.
32. Washington,N.L., Haendel,M.A., Mungall,C.J., Ashburner,M., Westerfield,M. and Lewis,S.E. (2009) Linking human diseases to animal models using ontology-based phenotype annotation. PLoS Biol., 7, e1000247.
33. Xiao,F., Zuo,Z., Cai,G., Kang,S., Gao,X. and Li,T. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res., 37, D105-D110.
34. Tripathi,R., Saini,H.K., Rad,R., Abreu-Goodger,C., van Dongen,S. and Enright,A.J. (2010) Messenger RNA and microRNA profiling during early mouse EB formation. Gene Expr. Patterns, 11, 334-344.
35. Nam,S., Kim,B., Shin,S. and Lee,S. (2008) miRGator: an integrated system for functional annotation of microRNAs. Nucleic Acids Res., 36, D159-D164. (Pubitemid 351149714)
36. Tang,F., Barbacioru,C., Bao,S., Lee,C., Nordman,E., Wang,X., Lao,K. and Surani,M.A. (2010) Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis. Cell Stem Cell, 6, 468-478.
37. Schlicker,A., Domingues,F.S., Rahnenfuhrer,J. and Lengauer,T. (2006) A new measure for functional similarity of gene products based on Gene Ontology. BMC Bioinformatics, 7, 302.
38. Lin,D. (1998) An information-theoretic definition of similarity. In fifteenth International Conference on Machine Learning, 296-304.
39. Pesquita,C., Faria,D., Bastos,H., Ferreira,A.E., Falcao,A.O. and Couto,F.M. (2008) Metrics for GO based protein semantic similarity: a systematic evaluation. BMC Bioinformatics, 9(Suppl 5), S4.
40. Jiang,Q., Wang,Y., Hao,Y., Juan,L., Teng,M., Zhang,X., Li,M., Wang,G. and Liu,Y. (2009) miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res., 37, D98-D104.
41. Livak,K.J. and Schmittgen,T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408. (Pubitemid 34164012)
42. Wu,X., Jiang,R., Zhang,M.Q. and Li,S. (2008) Network-based global inference of human disease genes. Mol. Syst. Biol., 4, 189.
43. Miller,B.H. and Wahlestedt,C. (2010) MicroRNA dysregulation in psychiatric disease. Brain Res., 1338, 89-99.
44. Ying,S.Y. and Lin,S.L. (2005) MicroRNA: fine-tunes the function of genes in zebrafish. Biochem. Biophys. Res. Commun., 335, 1-4.
45. Schroder,S., Dralle,H., Bay,V. and Bocker,W. (1989) [Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen]. Acta Med. Austriaca, 16, 2-5.
46. Subramanian,S., Goldstein,D.P., Parlea,L., Thabane,L., Ezzat,S., Ibrahim-Zada,I., Straus,S., Brierley,J.D., Tsang,R.W., Gafni,A. et al. (2007) Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid, 17, 1277-1288.
47. Takakura,S., Mitsutake,N., Nakashima,M., Namba,H., Saenko,V.A., Rogounovitch,T.I., Nakazawa,Y., Hayashi,T., Ohtsuru,A. and Yamashita,S. (2008) Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci., 99, 1147-1154. (Pubitemid 351676626)
48. Petrocca,F., Vecchione,A. and Croce,C.M. (2008) Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res., 68, 8191-8194.
49. Poliseno,L., Salmena,L., Riccardi,L., Fornari,A., Song,M.S., Hobbs,R.M., Sportoletti,P., Varmeh,S., Egia,A., Fedele,G. et al. (2010) Identification of the miR-106b-25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal, 3, ra29.
50. Ivanovska,I., Ball,A.S., Diaz,R.L., Magnus,J.F., Kibukawa,M., Schelter,J.M., Kobayashi,S.V., Lim,L., Burchard,J., Jackson,A.L. et al. (2008) MicroRNAs in the miR-106b family regulate p21/ CDKN1A and promote cell cycle progression. Mol. Cell. Biol., 28, 2167-2174. (Pubitemid 351429964)
51. Petrocca,F., Visone,R., Onelli,M.R., Shah,M.H., Nicoloso,M.S., de Martino,I., Iliopoulos,D., Pilozzi,E., Liu,C.G., Negrini,M. et al. (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 13, 272-286. (Pubitemid 351318375)
52. Inomata,M., Tagawa,H., Guo,Y.M., Kameoka,Y., Takahashi,N. and Sawada,K. (2009) MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood, 113, 396-402.
53. Yu,Z., Wang,C., Wang,M., Li,Z., Casimiro,M.C., Liu,M., Wu,K., Whittle,J., Ju,X., Hyslop,T. et al. (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell. Biol., 182, 509-517.
54. Venturini,L., Battmer,K., Castoldi,M., Schultheis,B., Hochhaus,A., Muckenthaler,M.U., Ganser,A., Eder,M. and Scherr,M. (2007) Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+cells. Blood, 109, 4399-4405. (Pubitemid 46743409)
55. Connolly,E., Melegari,M., Landgraf,P., Tchaikovskaya,T., Tennant,B.C., Slagle,B.L., Rogler,L.E., Zavolan,M., Tuschl,T. and Rogler,C.E. (2008) Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am. J. Pathol., 173, 856-864.
56. Matsubara,H., Takeuchi,T., Nishikawa,E., Yanagisawa,K., Hayashita,Y., Ebi,H., Yamada,H., Suzuki,M., Nagino,M., Nimura,Y. et al. (2007) Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene, 26, 6099-6105. (Pubitemid 47373805)
57. Northcott,P.A., Fernandez,L.A., Hagan,J.P., Ellison,D.W., Grajkowska,W., Gillespie,Y., Grundy,R., Van Meter,T., Rutka,J.T., Croce,C.M. et al. (2009) The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res., 69, 3249-3255.
58. Brock,M., Trenkmann,M., Gay,R.E., Michel,B.A., Gay,S., Fischler,M., Ulrich,S., Speich,R. and Huber,L.C. (2009) Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ. Res., 104, 1184-1191.
59. Hebert,S.S., Horre,K., Nicolai,L., Bergmans,B., Papadopoulou,A.S., Delacourte,A. and De Strooper,B. (2009) MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol. Dis., 33, 422-428.
60. Sampath,D., Calin,G.A., Puduvalli,V.K., Gopisetty,G., Taccioli,C., Liu,C.G., Ewald,B., Liu,C., Keating,M.J. and Plunkett,W. (2009) Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood, 113, 3744-3753.
61. Kim,Y.K., Yu,J., Han,T.S., Park,S.Y., Namkoong,B., Kim,D.H., Hur,K., Yoo,M.W., Lee,H.J., Yang,H.K. et al. (2009) Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res., 37, 1672-1681.
62. Li,Y., Tan,W., Neo,T.W., Aung,M.O., Wasser,S., Lim,S.G. and Tan,T.M. (2009) Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci., 100, 1234-1242.
63. Pichiorri,F., Suh,S.S., Ladetto,M., Kuehl,M., Palumbo,T., Drandi,D., Taccioli,C., Zanesi,N., Alder,H., Hagan,J.P. et al. (2008) MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc. Natl. Acad. Sci. USA, 105, 12885-12890.
64. Tagawa,H., Karube,K., Tsuzuki,S., Ohshima,K. and Seto,M. (2007) Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci., 98, 1482-1490. (Pubitemid 47241774)
65. Fontana,L., Fiori,M.E., Albini,S., Cifaldi,L., Giovinazzi,S., Forloni,M., Boldrini,R., Donfrancesco,A., Federici,V., Giacomini,P. et al. (2008) Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One, 3, e2236.
66. Ballabio,E., Mitchell,T., van Kester,M.S., Taylor,S., Dunlop,H.M., Chi,J., Tosi,I., Vermeer,M.H., Tramonti,D., Saunders,N.J. et al. (2010) MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood, 116, 1105-1113.
67. Landais,S., Landry,S., Legault,P. and Rassart,E. (2007) Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res., 67, 5699-5707. (Pubitemid 46985002)
68. Guttilla,I.K. and White,B.A. (2009) Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J. Biol. Chem., 284, 23204-23216.
69. Liu,T., Tang,H., Lang,Y., Liu,M. and Li,X. (2009) MicroRNA- 27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett., 273, 233-242.
70. Huang,S., He,X., Ding,J., Liang,L., Zhao,Y., Zhang,Z., Yao,X., Pan,Z., Zhang,P., Li,J. et al. (2008) Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int. J. Cancer, 123, 972-978. (Pubitemid 352032429)
71. Mi,S., Lu,J., Sun,M., Li,Z., Zhang,H., Neilly,M.B., Wang,Y., Qian,Z., Jin,J., Zhang,Y. et al. (2007) MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl. Acad. Sci. USA, 104, 19971-19976.
72. Xi,Y., Shalgi,R., Fodstad,O., Pilpel,Y. and Ju,J. (2006) Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin. Cancer Res., 12, 2014-2024.
73. Visone,R., Pallante,P., Vecchione,A., Cirombella,R., Ferracin,M., Ferraro,A., Volinia,S., Coluzzi,S., Leone,V., Borbone,E. et al. (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene, 26, 7590-7595. (Pubitemid 350207711)
74. Sayed,D., Hong,C., Chen,I.Y., Lypowy,J. and Abdellatif,M. (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res., 100, 416-424.
75. Arndt,G.M., Dossey,L., Cullen,L.M., Lai,A., Druker,R., Eisbacher,M., Zhang,C., Tran,N., Fan,H., Retzlaff,K. et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer, 9, 374.
76. Wang,G., Zhang,H., He,H., Tong,W., Wang,B., Liao,G., Chen,Z. and Du,C. (2009) Up-regulation of microRNA in bladder tumor tissue is not common. Int. Urol. Nephrol., 42, 95-102.
77. Eisenberg,I., Eran,A., Nishino,I., Moggio,M., Lamperti,C., Amato,A.A., Lidov,H.G., Kang,P.B., North,K.N., Mitrani- Rosenbaum,S. et al. (2007) Distinctive patterns of microRNA expression in primary muscular disorders. Proc. Natl. Acad. Sci. USA, 104, 17016-17021. (Pubitemid 350210983)
78. Hebert,C., Norris,K., Scheper,M.A., Nikitakis,N. and Sauk,J.J. (2007) High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol. Cancer, 6, 5.
79. Dixon-McIver,A., East,P., Mein,C.A., Cazier,J.B., Molloy,G., Chaplin,T., Andrew Lister,T., Young,B.D. and Debernardi,S. (2008) Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One, 3, e2141.
80. Marton,S., Garcia,M.R., Robello,C., Persson,H., Trajtenberg,F., Pritsch,O., Rovira,C., Naya,H., Dighiero,G. and Cayota,A. (2008) Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia, 22, 330-338. (Pubitemid 351250538)